The current stock price of NNOX is 4.36 USD. In the past month the price increased by 7.39%. In the past year, price decreased by -31.45%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.39 | 98.97B | ||
| CI | THE CIGNA GROUP | 9.79 | 74.29B | ||
| LH | LABCORP HOLDINGS INC | 16.79 | 22.02B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.6 | 21.39B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.86 | 19.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.58B | ||
| DVA | DAVITA INC | 13.03 | 8.60B | ||
| HIMS | HIMS & HERS HEALTH INC | 64.28 | 7.85B | ||
| CHE | CHEMED CORP | 20.08 | 6.44B | ||
| RDNT | RADNET INC | 218.42 | 6.38B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.91 | 6.13B | ||
| OPCH | OPTION CARE HEALTH INC | 19.85 | 4.80B |
Nano-X Imaging Ltd. engages in the development of medical imaging systems.
NANO-X IMAGING LTD
Ofer Tech Park, 94 Shlomo Shmeltzer Road
Petah Tikva 9085000 IL
CEO: Ran Poliakine
Employees: 165
Phone: 97237359202
Nano-X Imaging Ltd. engages in the development of medical imaging systems.
The current stock price of NNOX is 4.36 USD. The price increased by 26.38% in the last trading session.
NNOX does not pay a dividend.
NNOX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
10 analysts have analysed NNOX and the average price target is 7.91 USD. This implies a price increase of 81.31% is expected in the next year compared to the current price of 4.36.
NANO-X IMAGING LTD (NNOX) operates in the Health Care sector and the Health Care Providers & Services industry.
The outstanding short interest for NANO-X IMAGING LTD (NNOX) is 11.41% of its float.
ChartMill assigns a technical rating of 3 / 10 to NNOX. When comparing the yearly performance of all stocks, NNOX is a bad performer in the overall market: 75.22% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to NNOX. No worries on liquidiy or solvency for NNOX as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months NNOX reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS decreased by -14.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.21% | ||
| ROE | -34.03% | ||
| Debt/Equity | 0 |
10 analysts have analysed NNOX and the average price target is 7.91 USD. This implies a price increase of 81.31% is expected in the next year compared to the current price of 4.36.
For the next year, analysts expect an EPS growth of -9.46% and a revenue growth 12.16% for NNOX